Fujisawa Pharmaceutical to Outsource Cefzon Bulk Production to API Corporation

Fujisawa Pharmaceutical announced on March 23 that the company has agreed with API Corporation on the bulk production of Cefzon, Fujisawa's proprietary oral cepharosporin antibiotic. Under the terms of the agreement, API will handle production for overseas use and supply Fujisawa with Cefzon bulk. Since July 2002, API has been manufacturing and supplying Cefzon bulk for domestic use to Fujisawa. Through collaboration, Fujisawa aims to ensure the stable supply and quality preservation of Cefzon.

Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=9668)